MYC and cancer: Previous studies have suggested that c-MYC, as well as other oncogenes, can be overexpressed in cancer due to the activity of histone modifying proteins such as histone acetyltransferases (HAT), or histone readers such as bromodomain and extra-terminal domain (BET) proteins (10).